世界の抗喘息薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV02516)
◆英語タイトル:Global Anti-Asthmatic Drugs Market Insights and Forecast to 2026
◆商品コード:QYR20NV02516
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥413,400見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥620,100見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥826,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは抗喘息薬の世界市場について調査・分析した資料です。種類別(長期管理薬、クイックリリーフ薬(レスキュー薬)、アレルギー誘発性喘息治療薬)の市場規模、用途別(病院薬局、小売薬局、オンライン薬局)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別抗喘息薬の競争状況、市場シェア
・世界の抗喘息薬市場:種類別市場規模 2015年-2020年(長期管理薬、クイックリリーフ薬(レスキュー薬)、アレルギー誘発性喘息治療薬)
・世界の抗喘息薬市場:種類別市場規模予測 2021年-2026年(長期管理薬、クイックリリーフ薬(レスキュー薬)、アレルギー誘発性喘息治療薬)
・世界の抗喘息薬市場:用途別市場規模 2015年-2020年(病院薬局、小売薬局、オンライン薬局)
・世界の抗喘息薬市場:用途別市場規模予測 2021年-2026年(病院薬局、小売薬局、オンライン薬局)
・北米の抗喘息薬市場分析:米国、カナダ
・ヨーロッパの抗喘息薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの抗喘息薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の抗喘息薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの抗喘息薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Abdi Ibrahim、Ception Therapeutics、Elan、Innoviva、Novartis、Sanofi、Mitsubishi Tanabe Pharma、Menarini、Dong-A Socio Holdings、Lonza、Sosei、Regeneron Pharmaceuticals、Theravance Biopharma、Lonza
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Anti-Asthmatic Drugs Market
The global Anti-Asthmatic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Anti-Asthmatic Drugs Scope and Market Size
Anti-Asthmatic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Asthmatic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Anti-Asthmatic Drugs market is segmented into
Long-term Control Medications
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma

Segment by Application, the Anti-Asthmatic Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Regional and Country-level Analysis
The Anti-Asthmatic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Asthmatic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Asthmatic Drugs Market Share Analysis
Anti-Asthmatic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Asthmatic Drugs business, the date to enter into the Anti-Asthmatic Drugs market, Anti-Asthmatic Drugs product introduction, recent developments, etc.

The major vendors covered:
Abdi Ibrahim
Ception Therapeutics
Elan
Innoviva
Novartis
Sanofi
Mitsubishi Tanabe Pharma
Menarini
Dong-A Socio Holdings
Lonza
Sosei
Regeneron Pharmaceuticals
Theravance Biopharma
Lonza

【レポートの目次】

1 Study Coverage
1.1 Anti-Asthmatic Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Asthmatic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Asthmatic Drugs Market Size Growth Rate by Type
1.4.2 Long-term Control Medications
1.4.3 Quick-relief Medications (Rescue Medications)
1.4.4 Medications for Allergy-induced Asthma
1.5 Market by Application
1.5.1 Global Anti-Asthmatic Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Anti-Asthmatic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Asthmatic Drugs Revenue 2015-2026
2.1.2 Global Anti-Asthmatic Drugs Sales 2015-2026
2.2 Global Anti-Asthmatic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Asthmatic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Asthmatic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Anti-Asthmatic Drugs Competitor Landscape by Players
3.1 Anti-Asthmatic Drugs Sales by Manufacturers
3.1.1 Anti-Asthmatic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Anti-Asthmatic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Asthmatic Drugs Revenue by Manufacturers
3.2.1 Anti-Asthmatic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Asthmatic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Asthmatic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Asthmatic Drugs Revenue in 2019
3.2.5 Global Anti-Asthmatic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Asthmatic Drugs Price by Manufacturers
3.4 Anti-Asthmatic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Asthmatic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Asthmatic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Asthmatic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Anti-Asthmatic Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Asthmatic Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Asthmatic Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Asthmatic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Asthmatic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Asthmatic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Asthmatic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Asthmatic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Asthmatic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Anti-Asthmatic Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Asthmatic Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Asthmatic Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Asthmatic Drugs Price by Application (2015-2020)
5.2 Anti-Asthmatic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Asthmatic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Asthmatic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Asthmatic Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti-Asthmatic Drugs by Country
6.1.1 North America Anti-Asthmatic Drugs Sales by Country
6.1.2 North America Anti-Asthmatic Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Asthmatic Drugs Market Facts & Figures by Type
6.3 North America Anti-Asthmatic Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Anti-Asthmatic Drugs by Country
7.1.1 Europe Anti-Asthmatic Drugs Sales by Country
7.1.2 Europe Anti-Asthmatic Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Asthmatic Drugs Market Facts & Figures by Type
7.3 Europe Anti-Asthmatic Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Anti-Asthmatic Drugs by Region
8.1.1 Asia Pacific Anti-Asthmatic Drugs Sales by Region
8.1.2 Asia Pacific Anti-Asthmatic Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Asthmatic Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anti-Asthmatic Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Anti-Asthmatic Drugs by Country
9.1.1 Latin America Anti-Asthmatic Drugs Sales by Country
9.1.2 Latin America Anti-Asthmatic Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Asthmatic Drugs Market Facts & Figures by Type
9.3 Central & South America Anti-Asthmatic Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Anti-Asthmatic Drugs by Country
10.1.1 Middle East and Africa Anti-Asthmatic Drugs Sales by Country
10.1.2 Middle East and Africa Anti-Asthmatic Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Asthmatic Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Asthmatic Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Abdi Ibrahim
11.1.1 Abdi Ibrahim Corporation Information
11.1.2 Abdi Ibrahim Description and Business Overview
11.1.3 Abdi Ibrahim Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abdi Ibrahim Anti-Asthmatic Drugs Products Offered
11.1.5 Abdi Ibrahim Related Developments
11.2 Ception Therapeutics
11.2.1 Ception Therapeutics Corporation Information
11.2.2 Ception Therapeutics Description and Business Overview
11.2.3 Ception Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ception Therapeutics Anti-Asthmatic Drugs Products Offered
11.2.5 Ception Therapeutics Related Developments
11.3 Elan
11.3.1 Elan Corporation Information
11.3.2 Elan Description and Business Overview
11.3.3 Elan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Elan Anti-Asthmatic Drugs Products Offered
11.3.5 Elan Related Developments
11.4 Innoviva
11.4.1 Innoviva Corporation Information
11.4.2 Innoviva Description and Business Overview
11.4.3 Innoviva Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Innoviva Anti-Asthmatic Drugs Products Offered
11.4.5 Innoviva Related Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description and Business Overview
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Anti-Asthmatic Drugs Products Offered
11.5.5 Novartis Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Anti-Asthmatic Drugs Products Offered
11.6.5 Sanofi Related Developments
11.7 Mitsubishi Tanabe Pharma
11.7.1 Mitsubishi Tanabe Pharma Corporation Information
11.7.2 Mitsubishi Tanabe Pharma Description and Business Overview
11.7.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Products Offered
11.7.5 Mitsubishi Tanabe Pharma Related Developments
11.8 Menarini
11.8.1 Menarini Corporation Information
11.8.2 Menarini Description and Business Overview
11.8.3 Menarini Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Menarini Anti-Asthmatic Drugs Products Offered
11.8.5 Menarini Related Developments
11.9 Dong-A Socio Holdings
11.9.1 Dong-A Socio Holdings Corporation Information
11.9.2 Dong-A Socio Holdings Description and Business Overview
11.9.3 Dong-A Socio Holdings Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Dong-A Socio Holdings Anti-Asthmatic Drugs Products Offered
11.9.5 Dong-A Socio Holdings Related Developments
11.10 Lonza
11.10.1 Lonza Corporation Information
11.10.2 Lonza Description and Business Overview
11.10.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lonza Anti-Asthmatic Drugs Products Offered
11.10.5 Lonza Related Developments
11.1 Abdi Ibrahim
11.1.1 Abdi Ibrahim Corporation Information
11.1.2 Abdi Ibrahim Description and Business Overview
11.1.3 Abdi Ibrahim Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abdi Ibrahim Anti-Asthmatic Drugs Products Offered
11.1.5 Abdi Ibrahim Related Developments
11.12 Regeneron Pharmaceuticals
11.12.1 Regeneron Pharmaceuticals Corporation Information
11.12.2 Regeneron Pharmaceuticals Description and Business Overview
11.12.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Regeneron Pharmaceuticals Products Offered
11.12.5 Regeneron Pharmaceuticals Related Developments
11.13 Theravance Biopharma
11.13.1 Theravance Biopharma Corporation Information
11.13.2 Theravance Biopharma Description and Business Overview
11.13.3 Theravance Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Theravance Biopharma Products Offered
11.13.5 Theravance Biopharma Related Developments
11.14 Lonza
11.14.1 Lonza Corporation Information
11.14.2 Lonza Description and Business Overview
11.14.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Lonza Products Offered
11.14.5 Lonza Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Asthmatic Drugs Market Estimates and Projections by Region
12.1.1 Global Anti-Asthmatic Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Asthmatic Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Asthmatic Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Asthmatic Drugs Sales Forecast (2021-2026)
12.2.2 North America: Anti-Asthmatic Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Asthmatic Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Asthmatic Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Asthmatic Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Asthmatic Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Asthmatic Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Asthmatic Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Asthmatic Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Asthmatic Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Asthmatic Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Asthmatic Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Asthmatic Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Asthmatic Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Asthmatic Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Asthmatic Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Asthmatic Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Asthmatic Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Asthmatic Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Asthmatic Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Asthmatic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Anti-Asthmatic Drugs Market Segments
Table 2. Ranking of Global Top Anti-Asthmatic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Asthmatic Drugs Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Long-term Control Medications
Table 5. Major Manufacturers of Quick-relief Medications (Rescue Medications)
Table 6. Major Manufacturers of Medications for Allergy-induced Asthma
Table 7. Global Anti-Asthmatic Drugs Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Anti-Asthmatic Drugs Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-Asthmatic Drugs Sales by Regions 2015-2020 (K Doses)
Table 10. Global Anti-Asthmatic Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-Asthmatic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-Asthmatic Drugs Sales by Manufacturers (2015-2020) (K Doses)
Table 13. Global Anti-Asthmatic Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Anti-Asthmatic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Anti-Asthmatic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Asthmatic Drugs as of 2019)
Table 16. Anti-Asthmatic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Anti-Asthmatic Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Anti-Asthmatic Drugs Price (2015-2020) (USD/Dose)
Table 19. Anti-Asthmatic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Anti-Asthmatic Drugs Product Type
Table 21. Date of International Manufacturers Enter into Anti-Asthmatic Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-Asthmatic Drugs Sales by Type (2015-2020) (K Doses)
Table 24. Global Anti-Asthmatic Drugs Sales Share by Type (2015-2020)
Table 25. Global Anti-Asthmatic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Anti-Asthmatic Drugs Revenue Share by Type (2015-2020)
Table 27. Anti-Asthmatic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 28. Global Anti-Asthmatic Drugs Sales by Application (2015-2020) (K Doses)
Table 29. Global Anti-Asthmatic Drugs Sales Share by Application (2015-2020)
Table 30. North America Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 31. North America Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Anti-Asthmatic Drugs Sales by Type (2015-2020) (K Doses)
Table 35. North America Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Anti-Asthmatic Drugs Sales by Application (2015-2020) (K Doses)
Table 37. North America Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 39. Europe Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Anti-Asthmatic Drugs Sales by Type (2015-2020) (K Doses)
Table 43. Europe Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Anti-Asthmatic Drugs Sales by Application (2015-2020) (K Doses)
Table 45. Europe Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Anti-Asthmatic Drugs Sales by Region (2015-2020) (K Doses)
Table 47. Asia Pacific Anti-Asthmatic Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Anti-Asthmatic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Anti-Asthmatic Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-Asthmatic Drugs Sales by Type (2015-2020) (K Doses)
Table 51. Asia Pacific Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Anti-Asthmatic Drugs Sales by Application (2015-2020) (K Doses)
Table 53. Asia Pacific Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 55. Latin America Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Anti-Asthmatic Drugs Sales by Type (2015-2020) (K Doses)
Table 59. Latin America Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Anti-Asthmatic Drugs Sales by Application (2015-2020) (K Doses)
Table 61. Latin America Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 63. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-Asthmatic Drugs Sales by Type (2015-2020) (K Doses)
Table 67. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Anti-Asthmatic Drugs Sales by Application (2015-2020) (K Doses)
Table 69. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Table 70. Abdi Ibrahim Corporation Information
Table 71. Abdi Ibrahim Description and Major Businesses
Table 72. Abdi Ibrahim Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 73. Abdi Ibrahim Product
Table 74. Abdi Ibrahim Recent Development
Table 75. Ception Therapeutics Corporation Information
Table 76. Ception Therapeutics Description and Major Businesses
Table 77. Ception Therapeutics Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Ception Therapeutics Product
Table 79. Ception Therapeutics Recent Development
Table 80. Elan Corporation Information
Table 81. Elan Description and Major Businesses
Table 82. Elan Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Elan Product
Table 84. Elan Recent Development
Table 85. Innoviva Corporation Information
Table 86. Innoviva Description and Major Businesses
Table 87. Innoviva Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Innoviva Product
Table 89. Innoviva Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Major Businesses
Table 92. Novartis Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Novartis Product
Table 94. Novartis Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Major Businesses
Table 97. Sanofi Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofi Product
Table 99. Sanofi Recent Development
Table 100. Mitsubishi Tanabe Pharma Corporation Information
Table 101. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 102. Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Mitsubishi Tanabe Pharma Product
Table 104. Mitsubishi Tanabe Pharma Recent Development
Table 105. Menarini Corporation Information
Table 106. Menarini Description and Major Businesses
Table 107. Menarini Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Menarini Product
Table 109. Menarini Recent Development
Table 110. Dong-A Socio Holdings Corporation Information
Table 111. Dong-A Socio Holdings Description and Major Businesses
Table 112. Dong-A Socio Holdings Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Dong-A Socio Holdings Product
Table 114. Dong-A Socio Holdings Recent Development
Table 115. Lonza Corporation Information
Table 116. Lonza Description and Major Businesses
Table 117. Lonza Anti-Asthmatic Drugs Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Lonza Product
Table 119. Lonza Recent Development
Table 120. Sosei Corporation Information
Table 121. Sosei Description and Major Businesses
Table 122. Sosei Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Sosei Product
Table 124. Sosei Recent Development
Table 125. Regeneron Pharmaceuticals Corporation Information
Table 126. Regeneron Pharmaceuticals Description and Major Businesses
Table 127. Regeneron Pharmaceuticals Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Regeneron Pharmaceuticals Product
Table 129. Regeneron Pharmaceuticals Recent Development
Table 130. Theravance Biopharma Corporation Information
Table 131. Theravance Biopharma Description and Major Businesses
Table 132. Theravance Biopharma Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Theravance Biopharma Product
Table 134. Theravance Biopharma Recent Development
Table 135. Lonza Corporation Information
Table 136. Lonza Description and Major Businesses
Table 137. Lonza Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Lonza Product
Table 139. Lonza Recent Development
Table 140. Global Anti-Asthmatic Drugs Sales Forecast by Regions (2021-2026) (K Doses)
Table 141. Global Anti-Asthmatic Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Anti-Asthmatic Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Anti-Asthmatic Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Anti-Asthmatic Drugs Sales Forecast by Country (2021-2026) (K Doses)
Table 145. North America: Anti-Asthmatic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Anti-Asthmatic Drugs Sales Forecast by Country (2021-2026) (K Doses)
Table 147. Europe: Anti-Asthmatic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Anti-Asthmatic Drugs Sales Forecast by Region (2021-2026) (K Doses)
Table 149. Asia Pacific: Anti-Asthmatic Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Anti-Asthmatic Drugs Sales Forecast by Country (2021-2026) (K Doses)
Table 151. Latin America: Anti-Asthmatic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Anti-Asthmatic Drugs Sales Forecast by Country (2021-2026) (K Doses)
Table 153. Middle East and Africa: Anti-Asthmatic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Anti-Asthmatic Drugs Players
Table 158. Anti-Asthmatic Drugs Customers List
Table 159. Anti-Asthmatic Drugs Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Asthmatic Drugs Product Picture
Figure 2. Global Anti-Asthmatic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Long-term Control Medications Product Picture
Figure 4. Quick-relief Medications (Rescue Medications) Product Picture
Figure 5. Medications for Allergy-induced Asthma Product Picture
Figure 6. Global Anti-Asthmatic Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Online Pharmacy
Figure 10. Anti-Asthmatic Drugs Report Years Considered
Figure 11. Global Anti-Asthmatic Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-Asthmatic Drugs Sales 2015-2026 (K Doses)
Figure 13. Global Anti-Asthmatic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Anti-Asthmatic Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Anti-Asthmatic Drugs Sales Market Share by Region in 2019
Figure 16. Global Anti-Asthmatic Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Anti-Asthmatic Drugs Revenue Market Share by Region in 2019
Figure 18. Global Anti-Asthmatic Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Anti-Asthmatic Drugs Revenue in 2019
Figure 20. Anti-Asthmatic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Anti-Asthmatic Drugs Sales Market Share by Type in 2019
Figure 23. Global Anti-Asthmatic Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Anti-Asthmatic Drugs Revenue Market Share by Type in 2019
Figure 25. Global Anti-Asthmatic Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Anti-Asthmatic Drugs Sales Market Share by Application in 2019
Figure 28. Global Anti-Asthmatic Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Anti-Asthmatic Drugs Revenue Market Share by Application in 2019
Figure 30. North America Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 33. North America Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Anti-Asthmatic Drugs Market Share by Type in 2019
Figure 39. North America Anti-Asthmatic Drugs Market Share by Application in 2019
Figure 40. Europe Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 43. Europe Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Anti-Asthmatic Drugs Market Share by Type in 2019
Figure 55. Europe Anti-Asthmatic Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Anti-Asthmatic Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Anti-Asthmatic Drugs Revenue Market Share by Region in 2019
Figure 60. China Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Anti-Asthmatic Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Anti-Asthmatic Drugs Market Share by Application in 2019
Figure 84. Latin America Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Anti-Asthmatic Drugs Market Share by Type in 2019
Figure 95. Latin America Anti-Asthmatic Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Anti-Asthmatic Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Anti-Asthmatic Drugs Market Share by Application in 2019
Figure 108. North America Anti-Asthmatic Drugs Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 109. North America Anti-Asthmatic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Anti-Asthmatic Drugs Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 111. Europe Anti-Asthmatic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Anti-Asthmatic Drugs Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. Asia Pacific Anti-Asthmatic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Anti-Asthmatic Drugs Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Latin America Anti-Asthmatic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Anti-Asthmatic Drugs Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 117. Middle East and Africa Anti-Asthmatic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed


【掲載企業】

Abdi Ibrahim、Ception Therapeutics、Elan、Innoviva、Novartis、Sanofi、Mitsubishi Tanabe Pharma、Menarini、Dong-A Socio Holdings、Lonza、Sosei、Regeneron Pharmaceuticals、Theravance Biopharma、Lonza

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗喘息薬市場2026:インサイト・予測(Global Anti-Asthmatic Drugs Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。